Back

Higher hs-CRP predicts severe cardiovascular-kidney-metabolic syndrome stages: The NHANES 2015 – 2018 survey cycle

31 August 2026 (11:25 - 11:35)
Organised by: Logo
Congress Presentation Part of: Risk factors and prevention: biomarkers, inflammation, and cardiac mortality Biomarkers ESC Professional Premium Access ESC Congress 2026 European Society of Cardiology

About the speaker

Photo
Doctor Douglas Corsi

Rutgers Robert Wood Johnson Medical School, New Brunswick (United States of America)

4 More presentations in this session

Presentation thumbnail
Imaging-derived cardiovascular OrganAge predicts mortality and identifies smoking and diabetes as major accelerators of cardiovascular ageing in UK Biobank
Doctor M. Wamil (Oxford, GB)
Abstract Slides Video
Presentation thumbnail
Arterial elastance is a heritable and causal vascular endotype of hippocampal atrophy and cognitive decline
Doctor P. Masci (London, GB)
Abstract Slides Video
Presentation thumbnail
Interleukin-6 predicts cardiovascular events beyond standard modifiable risk factors in individuals without atherosclerotic cardiovascular disease
Mr M. Reugels (Aachen, DE)
Abstract Slides Video
Presentation thumbnail
The impact of inflammatory and cholesterol risk on cardiovascular events among statin-treated individuals: an observational study using UK Biobank data
Doctor D. Niederseer (Davos Wolfgang, CH)
Abstract Slides Video

Access the full session

Session thumbnail
Risk factors and prevention: biomarkers, inflammation, and cardiac mortality
Video

The Event

Event poster

ESC Congress 2026

31 August 2026 11:25 CET
You may be interested in
thumbnail
Congress Session
Metabolic drivers of cardiovascular disease
1 September 2025
thumbnail
Congress Presentation
Longitudinal hsCRP assessment in routine care refines residual inflammatory risk estimates
30 August 2026
thumbnail
Congress Presentation
Associations between C-reactive protein levels and mortality in individuals with atherosclerotic cardiovascular disease and chronic kidney disease: results from the UK Discover database
29 August 2025
thumbnail
Congress Presentation
Prevalence of clinically actionable hsCRP and implications for statin eligibility and residual ASCVD risk in the United States
30 August 2026

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources